SQLite Web: event_store.db

Update row 46844 in events

seq

Primary key. INTEGER

id

TEXT NOT NULL

kind

TEXT NOT NULL

ts

TEXT NOT NULL

actor

TEXT

subject_entity_ids

TEXT

payload

{"created_at":"2026-04-15T02:18:53.247056+00:00","dedupe_key":"signal_enriched:discovery_sec_filing_delta:b5c70614577e5a85","evidence_event_ids":["evt_cbe1ba053e5d"],"signal_type":"discovery_sec_filing_delta","source":"discovery_sec_filings","value":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1829802/0002038400-26-000001.txt","as_of":"2026-04-15T02:18:53.247056+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1829802/0002038400-26-000001.txt","company":"Sensei Biotherapeutics, Inc.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1829802/0002038400-26-000001.txt","article_chars":1872,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_7c1b4267f391407d","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1829802/0002038400-26-000001.txt","content_type":"text/plain","enriched_at":"2026-04-15T06:48:28.016410+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1829802/0002038400-26-000001.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1829802/0002038400-26-000001.txt","source_event_id":"evt_cbe1ba053e5d","source_quality":"medium","status_code":200,"version":"signal_enrichment_v2"},"form_type":"4","fp":"31b4f1d59b841c8a","kind":"sec_filing","published_at":"20260414","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.72,"dates_mentioned":["2026-04-14","2026-04-10","2027-04-10","2030-04-10"],"entities":[{"asset_class":"equity","name":"Sensei Biotherapeutics, Inc.","relevance":"high","symbol":"SNSE","type":"issuer"},{"asset_class":"person","name":"Josiah Craver","relevance":"high","symbol":"","type":"reporting_person"},{"asset_class":"equity","name":"Common Stock","relevance":"high","symbol":"","type":"security"},{"asset_class":"equity_derivative","name":"Stock Option (right to buy)","relevance":"medium","symbol":"","type":"derivative"}],"event_type":"other","information_gaps":["What changed vs prior known state is not provided in the signal; no prior filing/position is included to compare deltas.","The filing text excerpt does not explicitly state whether this is the first disclosure of this option or an amendment; only the current Form 4 contents are shown.","No explicit statement of whether the option was granted, exercised, or otherwise modified beyond the vesting/option terms shown."],"key_facts":["SEC filing: Form 4 (conformed submission type: 4) for Sensei Biotherapeutics, Inc.","Filed as of date: 2026-04-14; conform ed period of report: 2026-04-10.","Reporting person: Josiah Craver (company address listed as C/O Sensei Biotherapeutics, Inc.).","Transaction type indicated: PFO & PAO.","Security/transaction: Stock Option (right to buy).","Option exercise price: 29.89.","Number of shares associated with the option: 80,000 (shown as 80000).","Grant/vesting disclosure: 25% of the shares vest and become exercisable on April 10, 2027; remaining shares vest in 36 equal monthly installments thereafter; fully vested on the fourth anniversary of the grant date (April 10, 2030), subject to continuous service.","Signature: /s/ Josiah Craver dated 2026-04-14."],"numeric_claims":[{"label":"Option exercise price (USD)","value":"29.89"},{"label":"Option share amount","value":"80000"},{"label":"Vesting first tranche date","value":"2027-04-10"},{"label":"Monthly vesting installments","value":"36"},{"label":"Full vesting date","value":"2030-04-10"}],"primary_claim":"On 2026-04-10, reporting person Josiah Craver received a stock option for 80,000 shares with a stated vesting schedule and exercise price of $29.89, disclosed in a Form 4 filed 2026-04-14.","relevance_score":0.55,"sentiment":"neutral","source_quality":"medium","summary":"Sensei Biotherapeutics, Inc. (SNSE) filed a Form 4 on 2026-04-14 reporting a reporting person\u2019s stock option grant dated 2026-04-10.","topics":["SEC Form 4","stock option grant","vesting schedule","insider reporting"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 4 \u00b7 Sensei Biotherapeutics, Inc. \u00b7 Filed 20260414","ticker":"SNSE","tickers":["SNSE"],"title":"SNSE filed 4","url":"https://www.sec.gov/Archives/edgar/data/1829802/0002038400-26-000001.txt"}}

TEXT NOT NULL

source_ref

TEXT

confidence

REAL (default 0.0

dedupe_key

TEXT

episode_id

TEXT

created_at

TEXT NOT NULL (default strftime('%Y-%m-%dT%H:%M:%fZ','now')

Cancel